The Yokogawa Life Innovation Business is on the move
In order to drive the Yokogawa Life Innovation Business (LIB) forward in Europe, Dr. Gerd Heimlich joined Yokogawa as a…
The Yokogawa Life Innovation Business is on the move Read More »
Biotechnology: Focus on Microfactories
Biotechnology enables the generation of highly complex active ingredients that are used in the treatment of, for example, diabetes. Read…
Active agents against cancer
Yokogawa’s new HCA system, the CV8000, has a number of new features, including shorter testing cycles of new compounds and…